Search

everythinglearnresearchcommunity

for

Search:↓

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

FFA in young women is often missed, and no single treatment works best.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Excessive zinc intake can cause liver failure.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

The higher dose supplement was more effective in treating female hair loss.

Fennel extract cream can reduce hair thickness in people with excessive hair growth.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Low iron levels are strongly linked to chronic hair loss in women.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.

Nail loss may be a side effect of the MS drug teriflunomide.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Iron deficiency is linked to female pattern hair loss.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.